Literature DB >> 8597247

Beta 1,4-galactosyltransferase variations in rheumatoid arthritis.

A Alavi1, J Axford.   

Abstract

Evidence indicating an important link between glycosylation changes and autoimmune rheumatic disease is presented. Attention is especially focused on the interrelationship between reduced galactosylation of the oligosaccharides of IgG, auto-sensitization to which is thought to be of central importance in the pathogenesis of rheumatoid arthritis (RA), and the enzyme beta 1,4-Galactosyltransferase (GTase) that catalyses the addition of galactose to the oligosaccharide chains on this molecule. Data are presented to indicate that GTase undergoes a variety of normal and disease associated changes. These variations are believed to contribute to the pathological processes in rheumatoid disease, and a hypothesis is suggested, whereby disease is associated with the dysregulation of an integrated glycosylation network, comprising IgG galactosylation, lymphocytic GTase and anti-GTase antibodies, that is a component of the normal immune system.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8597247     DOI: 10.1007/978-1-4615-1885-3_19

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  3 in total

1.  Immunoglobulin G Glycosylation Changes in Aging and Other Inflammatory Conditions.

Authors:  Fabio Dall'Olio; Nadia Malagolini
Journal:  Exp Suppl       Date:  2021

2.  The p68 autoantigen characteristic of rheumatoid arthritis is reactive with carbohydrate epitope specific autoantibodies.

Authors:  S Bläss; C Meier; H W Vohr; M Schwochau; C Specker; G R Burmester
Journal:  Ann Rheum Dis       Date:  1998-04       Impact factor: 19.103

3.  Identification of novel plasma glycosylation-associated markers of aging.

Authors:  Mariangela Catera; Vincenzo Borelli; Nadia Malagolini; Mariella Chiricolo; Giulia Venturi; Celso A Reis; Hugo Osorio; Provvidenza M Abruzzo; Miriam Capri; Daniela Monti; Rita Ostan; Claudio Franceschi; Fabio Dall'Olio
Journal:  Oncotarget       Date:  2016-02-16
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.